Cargando…
Barbiturates and pyrazolopyridines for the treatment of postpartum depression—repurposing of two drug classes
Zulresso (brexanolone) is an aqueous formulation of the neurosteroid, allopregnanolone, and the only FDA-approved medication for the treatment of postpartum depression (PPD). While brexanolone is effective for the treatment of PPD, lengthy infusion time and high cost can be prohibitive. Failure of G...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995982/ https://www.ncbi.nlm.nih.gov/pubmed/36909181 http://dx.doi.org/10.3389/fphar.2023.1139889 |